Pharma downplays 25% tariff impact: US healthcare could feel the blow instead of India- what sector experts say
[ad_1] India’s pharmaceutical sector has given its insights into US President Donald Trump’s announcement of a 25 per cent tariff on all Indian imports starting August 1, warning that the move could significantly disrupt American healthcare rather than weaken Indian industry. While uncertainty remains about whether pharmaceuticals will fall under the new tariff list- given…